Larvol Delta - Phase-IIb-study-of-crenolanib-with-ramucirumab-and-paclitaxel-as-secondline-therapy-for-advanced-esophagogastric-adenocarcinoma

paclitaxel - Generic mfg.

Cyramza (ramucirumab) - Eli Lilly

crenolanib besylate (ARO-002) - AROG

http://www.ncbi.nlm.nih.gov/pubmed/35066693

Jan 26, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next